Trial reportScientific reports2026
Effectiveness of telemonitoring on clinical outcomes in patients with heart failure: a randomized clinical trial.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the advancements in information technology in recent years, there is a possibility of implementing technology-based interventions to train, monitor clinical outcomes, and improve patients with heart failure (HF) ‘s self-care abilities. This study was conducted to determine the effectiveness of telemonitoring on clinical outcomes of patients with HF. In this parallel randomized clinical trial with blinded outcome assessment and data analysis, 136 patients with HF were allocated to intervention or control groups. The intervention group received structured telemonitoring, education, and weekly follow-up for eight weeks. Self-care (primary outcome) was measured using the European Heart Failure Self-Care Behavior Scale, and medication adherence (secondary outcome) was assessed using the Medication Adherence Rating Scale at baseline and four weeks post-intervention. A total of 136 patients were enrolled, and 123 completed the study (intervention = 61; control = 62). Baseline demographic characteristics and outcome measures were comparable between the two groups. Following the intervention, self-care scores significantly improved in the intervention group compared with the control group (p < 0.001), with a large effect size (Cohen’s d = − 1.26; 95% CI − 1.64 to − 0.87). Medication adherence also showed a significant improvement in the intervention group compared with the control group after adjusting for baseline values (p < 0.001), with a moderate-to-large effect size (Cohen’s d = 0.73; 95% CI 0.37 to 1.10). Structured telemonitoring was associated with improvements in self-care and medication adherence in patients with HF. These findings suggest that technology-based follow-up programs may support better patient engagement and clinical outcomes. Further studies are needed to confirm the long-term benefits and sustainability of these interventions.Trial Registration: IRCT20230221057476N1 (Date 28/06/2023).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.